VINC - Vincerx Pharma Inc. Price-to-Revenue Ratio

Symbol and logo of brand Vincerx (VINC)

Vincerx Pharma, Inc. (VINC) relies on outsourcing production and testing to maintain flexibility. The current P/S multiple on the GURU.Markets terminal generates a chart of the indicator, where the level represents the current value. Geopolitics complicates patent protection and component logistics. Simultaneously, Vincerx Pharma, Inc. (VINC) is implementing software robots for leukemia treatment data analysis and testing automated molecule screening.

Vincerx (VINC): Price-to-Revenue Ratio from 07/04/2022 to 11/15/2026

Analytical breakdowns for Vincerx Pharma, Inc. (VINC)

- stock price and consensus target price:
Fundamental company analysis:vincerx.com, VINC
Original product of Vincerx

The P/S ratio determines the market value of one dollar of revenue, allowing an investor to assess the degree of overpayment for an asset by mathematically linking market capitalization to actual earnings. By analyzing the P/S trajectory, one can identify deviations in the valuation of Vincerx Pharma, Inc. (VINC) from its fundamentals, which is critical amid patent disputes and a valuation dependent on FDA clinical trial results.